Archive | FDA Drug Advisory RSS feed for this section
Possible links between esophageal cancer and osteoporosis drugs
The FDA is investigating whether certain drugs used to treat osteoporosis are associated with an increased risk of esophageal cancer. At this time, the FDA has not found conclusive evidence linking the medications, called oral bisphosphonates, with esophageal cancer. However, the agency is continuing to evaluate all data available and will alert the public if [...]
Continue reading...Studies show Depakote has ties to birth defects
20. July 2011
The use of Depakote has been linked to a variety of birth defects in the babies of mothers who took the drug while pregnant. Birth defects involving the face, skull, brain, spinal cord, heart, and blood vessels have been linked to Depakote use. Depakote, an anti-seizure medication, was originally approved by the FDA in 1983. [...]
Continue reading...Causes of spina bifida
18. July 2011
Depakote among causes of spina bifida Each year, numerous babies are born with the harmful birth defect spina bifida. Babies with spina bifida are born with improperly formed spines that do not close correctly around their spinal cords. Spina bifida is believed to be caused by a combination of genetic and environmental factors. Many instances [...]
Continue reading...Mothers filing suit for omphalocele with Zoloft
13. July 2011
Mothers across the country are joining in a lawsuit against the makers of the antidepressant Zoloft, claiming that taking the drug while pregnant caused them to give birth to infants with birth defects. Studies have tied Zoloft use to a number of different defects and health problems, including omphalocele. Omphalocele is a dangerous condition in [...]
Continue reading...Craniosynostosis part of lawsuit against Zoloft maker
13. July 2011
Craniosynostosis, a condition that leads to abnormally shaped heads in babies, has been linked to use of the drug Zoloft while the babies’ mothers were pregnant. Studies show that women who took Zoloft during pregnancy were more likely to give birth to infants with certain birth defects, including defects involving the heart, head, and lungs. [...]
Continue reading...Zoloft shown to increase risk of persistent fetal circulation
12. July 2011
Results from a 2006 study suggest that taking Zoloft during pregnancy caused numerous women to give birth to babies with persistent fetal circulation, a harmful birth defect. The condition is also referred to as persistent pulmonary hypertension of the newborn (PPHN). Infants with persistent fetal circulation have lungs that do not receive adequate blood flow. [...]
Continue reading...Hypoplastic left heart syndrome part of Zoloft lawsuit
7. July 2011
Infants whose mothers took the antidepressant Zoloft may be at increased risk for heart defects and other health problems at birth. Studies have tied Zoloft use during pregnancy to health risks in infants born to the mothers who took it. Heart defects are among the most prominent health problems found in these children. One heart [...]
Continue reading...Transposition of the great arteries found in babies exposed to Zoloft
6. July 2011
Research has drawn a link between certain heart defects in infants and use of the drug Zoloft by their mothers during pregnancy. One of these heart defects is transposition of the great arteries (TGA). In babies with this condition, the heart’s two major vessels – the pulmonary artery and the aorta – are transposed, or [...]
Continue reading...Heart defects central in lawsuit against Zoloft maker
2. July 2011
Heart defects are among the main health problems blamed on Zoloft in a growing lawsuit against the makers of the antidepressant. The lawsuit is based on evidence that the use of Zoloft during pregnancy led to numerous birth defects in babies across the country. The risk appears to be greatest when Zoloft was taken during [...]
Continue reading...FDA warns of lower cognitive functioning with Valproate
30. June 2011
The FDA has reported that the children of mothers who took the drug Valproate during pregnancy appear to have lower levels of cognitive functioning than other children. Valproate drugs include the following: divalproex sodium (Depakote, Depakote ER, Depakote CP), valproate sodium (Depacon), valproic acid (Stavzor, Depakene), and the generic versions of these drugs. Valproate is [...]
Continue reading...
- Risperdal (Resperidone)
- FDA issues warning on Advair, Symbicort, Foradil and Serevent
- Crestor Linked to Rhabdomyolysis (Fatal Muscle Disease)
- Benzoyl Peroxide Acne Cream 10% Contained Burkholderia Cepacia Bacteria
- Merck’s Vioxx $4.85 billion payouts to begin in August
- Zoloft lawsuit
- Fluoroquinolone Antimicrobial Drugs
- Arthritis Drug Vioxx Recalled
- Tysabri monotherapy and progressive multifocal leukoencephalopathy
- FDA recalls Zyprexa
- None found
- Pfizer birth control pills may not prevent pregnancy
- Adcetris brain infection death
- FDA warning on Multaq and Increased Risk of Death
- SSRI and Potential Risk of Persistent Pulmonary Hypertension
- Serious Complications Associated with Vaginal Mesh devices
- Actos Lawsuit
- Infant heart defect risks increase with SSRIs
- Birth defects more likely with SSRI use
- Diflucan during pregnancy poses risk to infants
- Birth defects caused by many factors
26. July 2011
0 Comments